1. Home
  2. BIO vs CX Comparison

BIO vs CX Comparison

Compare BIO & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CX
  • Stock Information
  • Founded
  • BIO 1952
  • CX 1906
  • Country
  • BIO United States
  • CX Mexico
  • Employees
  • BIO N/A
  • CX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CX Building Materials
  • Sector
  • BIO Industrials
  • CX Industrials
  • Exchange
  • BIO Nasdaq
  • CX Nasdaq
  • Market Cap
  • BIO 9.1B
  • CX 8.5B
  • IPO Year
  • BIO N/A
  • CX 1999
  • Fundamental
  • Price
  • BIO $342.01
  • CX $5.41
  • Analyst Decision
  • BIO Strong Buy
  • CX Buy
  • Analyst Count
  • BIO 4
  • CX 6
  • Target Price
  • BIO $414.00
  • CX $7.70
  • AVG Volume (30 Days)
  • BIO 158.1K
  • CX 11.0M
  • Earning Date
  • BIO 02-13-2025
  • CX 02-06-2025
  • Dividend Yield
  • BIO N/A
  • CX 0.78%
  • EPS Growth
  • BIO N/A
  • CX N/A
  • EPS
  • BIO N/A
  • CX 0.02
  • Revenue
  • BIO $2,580,209,000.00
  • CX $17,249,067,000.00
  • Revenue This Year
  • BIO N/A
  • CX N/A
  • Revenue Next Year
  • BIO $2.92
  • CX $0.05
  • P/E Ratio
  • BIO N/A
  • CX $17.28
  • Revenue Growth
  • BIO N/A
  • CX 5.20
  • 52 Week Low
  • BIO $262.12
  • CX $5.00
  • 52 Week High
  • BIO $387.99
  • CX $9.27
  • Technical
  • Relative Strength Index (RSI)
  • BIO 53.78
  • CX 39.00
  • Support Level
  • BIO $335.42
  • CX $5.60
  • Resistance Level
  • BIO $351.96
  • CX $5.88
  • Average True Range (ATR)
  • BIO 9.09
  • CX 0.13
  • MACD
  • BIO 2.06
  • CX -0.03
  • Stochastic Oscillator
  • BIO 59.23
  • CX 12.84

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.

Share on Social Networks: